Thomas Ilic, MD
Psychiatry · Milwaukee, WINPI 1912438417
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $258,370 of the $324,272 with a category attached, or 79.7%. 7 manufacturers reported payments, led by Johnson & Johnson at 58.2% of the total. 2025 is the largest year on record at $209,165, more than ten times the $141 reported in 2022. Among psychiatry clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 428 payments — averaging $757.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$189K
- Axsome Therapeutics, Inc.$124K
- E.r. Squibb & Sons, L.L.C.$8K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$255
- Janssen Scientific Affairs, LLC$180
- plus $118 from 1 others
What the payments were for
- Consulting fees$8,1153%
- Speaking & faculty fees$258,37080%
- Travel & lodging$48,70515%
- Food & beverage$8,9713%
- Education$1110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 258 | $188,857 |
| Axsome Therapeutics, Inc. | 147 | $124,210 |
| E.r. Squibb & Sons, L.L.C. | 13 | $8,337 |
| AbbVie | 4 | $2,315 |
| Teva Pharmaceuticals USA, Inc. | 3 | $255 |
| Janssen Scientific Affairs, LLC | 2 | $180 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$324,272 in reported general payments places this provider in the 95th percentile of 543 psychiatry providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atomoxetine Hcl | 11 | $1,133 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $762 |
| Duloxetine Hcl | 13 | $399 |
| Bupropion XlBupropion Hcl | 22 | $378 |
| Quetiapine Fumarate | 39 | $341 |
| Zaleplon | 12 | $325 |
| Olanzapine | 16 | $304 |
| Mirtazapine | 27 | $279 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $275 |
| Hydroxyzine Hcl | 18 | $192 |
| Escitalopram Oxalate | 28 | $184 |
| Methylphenidate Hcl | 11 | $152 |
| Nortriptyline Hcl | 11 | $112 |
| Alprazolam | 15 | $108 |
| Lorazepam | 16 | $87 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Milwaukee
- Jay WinstonMilwaukee$238K
- Joseph BurgarinoMilwaukee$111K
- Jacob BehrensMilwaukee$94K
- Selahattin KurterMilwaukee$17K
- Harold HarschMilwaukee$8K
- Ajay SehgalMilwaukee$7K
- James WinstonMilwaukee$7K
- Edgar JacksonMilwaukee$5K
- Ali ArtarMilwaukee$5K
- Robert RuskiewiczMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.